Childrens Place Inc
7 nominees · 4 ballot items.
Election of seven directors; Ratification of BDO as independent auditors; Approval to increase 1,200,000 shares under 2011 Equity Incentive Plan; Advisory Say-on-Pay vote on named executive officer compensation.
Follow how the vote landed and what changed on Childrens Place Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot4
- 1
Election of Seven Members of the Board of Directors
ManagementBoard: FORElect seven director nominees (Turki Saleh A. AlRajhi, Muhammad Asif Seemab, Hussan Arshad, Douglas Edwards, Kim Roy, Rhys Summerton and Muhammad Umair), each to serve a one-year term until the 2027 annual meeting or until successors are elected and qualified.
- 2
Ratification of Selection of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the Audit Committee’s selection of BDO USA, P.C. as the Company’s independent registered public accounting firm for fiscal 2026.
- 3
Approval of an Increase in the Number of Shares of Common Stock Available for Issuance Under Our 2011 Equity Incentive Plan
ManagementBoard: FORApprove an increase of 1,200,000 shares of common stock available for issuance under the Company’s 2011 Equity Incentive Plan to replenish the plan’s share reserve.
More detail
This management proposal requests shareholder approval to add 1,200,000 shares to the existing reserve under the Company’s 2011 Equity Incentive Plan—currently the sole plan used to grant long-term incentive equity awards to employees and non-employee directors. Management frames the request as a practical necessity: with only 300,034 shares remaining in the plan and ongoing grants across time-based and performance-based vehicles (TRSUs, PRSUs, deferred cash awards and performance cash awards), the Company expects to exhaust the reserve imminently and argues that replenishment is required to avoid material changes to its compensation program. The board emphasizes retention and alignment objectives: equity awards are positioned as critical to attracting and retaining talent during a period of leadership transition and macroeconomic uncertainty (tariffs, inflation, geopolitical tensions), and maintaining incentive structures tied to Adjusted Free Cash Flow and other performance metrics. Governance features—such as a fixed share pool (no evergreen), anti-repricing limits without shareholder approval, double-trigger change-in-control protections, minimum vesting periods, director grant caps and clawback provisions—are highlighted to mitigate typical shareholder concerns about dilution and governance. The proposal’s approval would add roughly 1,200,000 shares to a current outstanding base of 22.2 million shares—implying a potential dilution impact that the company estimates will sustain its granting needs until approximately fiscal 2029. The board’s recommendation for a FOR vote is justified on the basis that continued grant capacity supports the Company’s transformation strategy, preserves competitive compensation practices, and aligns management and shareholders, while retaining specific safeguards to limit abuse; however, voting shareholders should weigh the dilution trade-off against the expected retention and performance benefits and consider the company’s recent financial results and share issuance history when assessing the proposal’s prudence.
- 4
Advisory Vote on Named Executive Officer Compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve the compensation of the Company’s named executive officers for fiscal 2025 as disclosed in the proxy statement.
More detail
This non-binding management-sponsored Say-on-Pay proposal asks shareholders to endorse the company’s disclosed executive compensation practices for fiscal 2025, including base salaries, a modified annual bonus approach (where the HC&C Committee exercised discretion due to leadership transitions and external macroeconomic headwinds), and a mix of long-term incentives comprised of TRSUs, deferred cash awards and performance cash awards tied to Adjusted Free Cash Flow over multi-year periods. Management argues that the program balances retention (through staged vesting and deferred cash), performance alignment (performance cash awards and PRSUs tied to Adjusted Free Cash Flow), and governance safeguards (clawbacks, double-trigger change-in-control protections, and independent committee oversight). The Board frames the advisory vote as consultative but important: although non-binding, the Board and HC&C Committee pledge to consider voting results in future compensation decisions. For an informed vote, shareholders should consider recent outcomes (e.g., certain PRSUs granted in 2024 paid out 0% for 2025 due to missing Adjusted Free Cash Flow thresholds), the use of discretion in 2025 annual bonuses (some NEOs received discretionary payouts while the CEO received $0), and the broader context of the Company’s transformation and financial performance when evaluating whether pay outcomes align with pay-for-performance expectations.
Nominees on the ballot7
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Mithaq Capital SPC | 61.1% | 13,593,236 | $41M |
| 2 | Shay Capital LLC | 4.2% | 925,244 | $3M |
| 3 | BlackRock, Inc. | 1.4% | 313,741 | $957K |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 1.4% | 312,981 | $955K |
| 5 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.0% | 221,115 | $674K |
| 6 | IMMERSION CORP | 0.9% | 205,366 | $626K |
| 7 | UBS Group AG | 0.9% | 191,704 | $585K |
| 8 | JANE STREET GROUP, LLC | 0.5% | 104,945 | $320K |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 0.4% | 89,857 | $274K |
| 10 | GROUP ONE TRADING LLC | 0.4% | 89,046 | $272K |
Other Consumer Cyclical sector meetings6
Upcoming shareholder meetings at Childrens Place Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Childrens Place Inc 2026 annual meeting?
- Childrens Place Inc (PLCE) holds its 2026 annual shareholder meeting on Wednesday, May 6, 2026.
- What is the record date for the Childrens Place Inc 2026 meeting?
- The record date for the Childrens Place Inc 2026 meeting is Monday, March 9, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Childrens Place Inc's 2026 meeting?
- The board is presenting 7 director nominees at the Childrens Place Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Childrens Place Inc 2026 meeting?
- Shareholders will vote on 4 proposals at the Childrens Place Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.